New Era? ‘Double Selective’ Antibiotic Spares the Microbiome
A new antibiotic uses a never-before-seen mechanism to deliver a direct hit on tough-to-treat infections while leaving beneficial microbes alone.
Publisher: Medscape
New Brain Death Criteria: Reaching Consensus
I’m Dr Andrew Wilner. Today, I have the pleasure of speaking with Dr Lucas Elijovich. Lucas is a colleague of mine, and he’s also a specialist in critical care and director of neurocritical care at University of Tennessee Health Science Center (UTHSC), where we both work.
SGLT2 Inhibitors for Diabetes Safe, Effective in Older Adults
Sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes appear to be as safe and effective in people aged 65 years and older as in younger individuals, new research suggests. Findings from a real-world observational study of 50 older adults with type 2 diabetes were recently presented here at the International… Read More
RSV: Investigational Drug Shows Promise in Challenge Study
John P. DeVincenzo, MD, from the University of Tennessee College of Medicine and the Children’s Foundation Research Institute at Le Bonheur Children’s Hospital, Memphis, Tennessee, and colleagues published their findings in the November 19 issue of the New England Journal of Medicine.
Mirror Therapy Needs Time to Work in Severe Phantom Pain
“Mirror therapy actually does work, and it seems to have a very rapid response,” said Jack Tsao, MD, DPhil, professor of neurology at the University of Tennessee Health Science Center in Memphis.
Dr. Dagogo-Jack Argues Against Changing Fasting Guidelines
One of those who doesn’t see the need for change is Dr Samuel E Dagogo-Jack (division of endocrinology, diabetes, and metabolism, and director, Clinical Research Center, University of Tennessee Health Science Center, Memphis), who is the incoming president, medicine and science, of the American Diabetes Association.